In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Cerence Inc’s stock clocked out at $6.95, up 1.02% from its previous closing price of $6.88. In other words, the price has increased by $1.02 from its previous closing price. On the day, 1.25 million shares were traded. CRNC stock price reached its highest trading level at $7.375 during the session, while it also had its lowest trading level at $5.94.
Ratios:
To gain a deeper understanding of CRNC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.82. For the most recent quarter (mrq), Quick Ratio is recorded 1.27 and its Current Ratio is at 1.29. In the meantime, Its Debt-to-Equity ratio is 2.24 whereas as Long-Term Debt/Eq ratio is at 1.71.
On January 22, 2025, Needham Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $16.
Wells Fargo Downgraded its Overweight to Equal Weight on May 10, 2024, whereas the target price for the stock was revised from $25 to $6.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 13 ’25 when Mentz Christian sold 3,600 shares for $14.73 per share. The transaction valued at 53,028 led to the insider holds 142,747 shares of the business.
BEAUDOIN THOMAS L sold 5,000 shares of CRNC for $58,400 on Feb 03 ’25. The Director now owns 173,966 shares after completing the transaction at $11.68 per share. On Feb 03 ’25, another insider, THOMAS L. BEAUDOIN, who serves as the Director of the company, bought 5,000 shares for $11.68 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRNC now has a Market Capitalization of 300233056 and an Enterprise Value of 459586080. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.23 while its Price-to-Book (P/B) ratio in mrq is 2.48. Its current Enterprise Value per Revenue stands at 1.883 whereas that against EBITDA is -41.204.
Stock Price History:
The Beta on a monthly basis for CRNC is 2.87, which has changed by -0.5173611 over the last 52 weeks, in comparison to a change of -0.028342128 over the same period for the S&P500. Over the past 52 weeks, CRNC has reached a high of $27.50, while it has fallen to a 52-week low of $2.34. The 50-Day Moving Average of the stock is -37.59%, while the 200-Day Moving Average is calculated to be 6.45%.
Shares Statistics:
It appears that CRNC traded 4.24M shares on average per day over the past three months and 1266820 shares per day over the past ten days. A total of 42.99M shares are outstanding, with a floating share count of 39.95M. Insiders hold about 7.53% of the company’s shares, while institutions hold 77.58% stake in the company. Shares short for CRNC as of 1741910400 were 9181437 with a Short Ratio of 2.17, compared to 1739491200 on 8413330. Therefore, it implies a Short% of Shares Outstanding of 9181437 and a Short% of Float of 21.280001000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
